Lexeo Therapeutics, Inc. (LXEO) Tops Q2 EPS by 31c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q2 EPS of ($0.60), $0.31 better than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Uber sells part of its Aurora stake in block trade - Bloomberg
• ZoomInfo (GTM) 27K contracts of October 2 weekly 3 puts trade share price up 3.8%
• Taylor Devices (TAYD) Misses Q4 EPS by 31c